n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride has been researched along with rimcazole in 4 studies
| Studies (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Trials (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Recent Studies (post-2010) (n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride) | Studies (rimcazole) | Trials (rimcazole) | Recent Studies (post-2010) (rimcazole) |
|---|---|---|---|---|---|
| 5 | 0 | 2 | 103 | 2 | 13 |
| 98 | 0 | 29 | 103 | 2 | 13 |
| Protein | Taxonomy | n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride (IC50) | rimcazole (IC50) |
|---|---|---|---|
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.14 | |
| Sigma non-opioid intracellular receptor 1 | Cavia porcellus (domestic guinea pig) | 1.0235 | |
| Scavenger receptor class B member 1 | Homo sapiens (human) | 1.2 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.9196 | |
| Sigma non-opioid intracellular receptor 1 | Rattus norvegicus (Norway rat) | 1.4152 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Katz, JL; Kopajtic, T; Newman, AH | 1 |
| Collina, S; Cortesi, M; Curti, D; Laurini, E; Marra, A; Pace, V; Paolillo, M; Pricl, S; Rossi, D; Rui, M; Schepmann, D; Schinelli, S; Tesei, A; Urban, E; Wűnsch, B; Zamagni, A | 1 |
| Araki, H; Ogawa, S; Okuyama, S; Otomo, S; Tsuchida, K | 1 |
| Cao, J; Hiranita, T; Katz, JL; Kohut, SJ; Kopajtic, T; Newman, AH; Soto, PL; Tanda, G | 1 |
4 other study(ies) available for n,n-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride and rimcazole
| Article | Year |
|---|---|
Dual DAT/sigma1 receptor ligands based on 3-(4-(3-(bis(4-fluorophenyl)amino)propyl)piperazin-1-yl)-1-phenylpropan-1-ol.
Topics: Animals; Carbazoles; Cocaine; Combinatorial Chemistry Techniques; Dopamine Plasma Membrane Transport Proteins; Molecular Structure; Piperazines; Protein Binding; Rats; Receptors, sigma; Stereoisomerism; Structure-Activity Relationship | 2008 |
Synthesis and biological evaluation of new aryl-alkyl(alkenyl)-4-benzylpiperidines, novel Sigma Receptor (SR) modulators, as potential anticancer-agents.
Topics: Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Molecular Structure; PC12 Cells; Piperidines; Rats; Receptors, sigma | 2016 |
The sigma-selective ligand NE-100 attenuates the effect of phencyclidine in a rat diving model.
Topics: Animals; Anisoles; Carbazoles; Diving; Male; Motor Activity; Phencyclidine; Piperidines; Propylamines; Pyrimidines; Rats; Rats, Wistar; Receptors, sigma | 1995 |
Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and σ receptors.
Topics: Animals; Anisoles; Antipsychotic Agents; Carbazoles; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Male; Molecular Targeted Therapy; Oxalates; Piperidines; Propylamines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, sigma; Reinforcement, Psychology; Self Administration | 2011 |